目次

Table of Contents
Description
Search Inside Report

1 Introduction
1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered And Regional Scope
1.3.2 Inclusions & Exclusions
1.3.3 Years Considered
1.3.4 Currency Considered
1.4 Stakeholders

2 Research Methodology
2.1 Research Data
2.1.1 Secondary Data
2.1.2 Primary Data
2.2 Market Estimation Methodology
2.2.1 Market Estimation
2.2.2 Insights From Primary Experts
2.2.3 Top-down Approach
2.3 Market Growth Rate Projection
2.4 Data Triangulation
2.5 Research Assumptions
2.6 Research Limitations
2.7 Risk Analysis

3 Executive Summary

4 Premium Insights
4.1 Gene Delivery Technologies Market Overview
4.2 North America: Gene Delivery Technologies Market, By Application (2023)
4.3 Gene Delivery Technologies Market Share, By Mode, 2024 Vs. 2029
4.4 Gene Delivery Technologies Market: Geographic Growth Opportunities

5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Growing Demand For Personalized Medicine And Cell & Gene Therapies
5.2.1.2 Increased Investments In Gene Therapy Research
5.2.1.3 Expanding Applications In Vaccine Development & Cancer Immunotherapy
5.2.2 Restraints
5.2.2.1 High Costs Of Gene Delivery Systems
5.2.3 Opportunities
5.2.3.1 Advancements In Gene Editing Technologies & Nanotechnology
5.2.3.2 Integration With Digital Technologies Such As Ai & Ml
5.2.4 Challenges
5.2.4.1 Scalability Of Production
5.3 Ecosystem Analysis
5.3.1 Product Providers
5.3.2 End Users
5.3.3 Regulatory Bodies
5.4 Technology Analysis
5.4.1 Key Technologies
5.4.1.1 Microinjection
5.4.1.2 Electroporation
5.4.1.3 Sonoporation
5.4.2 Complementary Technologies
5.4.2.1 Gene Editing Technologies
5.4.2.2 Bioinformatics And Computational Tools
5.4.3 Adjcent Technologies
5.4.3.1 Nanotechnology And Nano-carriers
5.5 Pricing Analysis
5.5.1 Average Selling Price Trend Of Reagents/Consumables, By Key Player
5.5.2 Average Selling Price Trend Of Instruments, By Region
5.6 Value Chain Analysis
5.7 Supply Chain Analysis
5.8 Patent Analysis
5.9 Trade Analysis
5.9.1 Import Data For Machines And Apparatus For Electroplating, Electrolysis Or Electrophoresis (Hs Code: 854330)
5.9.2 Export Data For Machines And Apparatus For Electroplating, Electrolysis Or Electrophoresis (Hs Code: 854330)
5.10 Key Conferences And Events, 2024-2025
5.11 Regulatory Landscape
5.11.1 Regulatory Bodies, Government Agencies, And Other Organizations
5.11.2 Regulatory Framework
5.11.2.1 North America
5.11.2.2 Europe
5.11.2.3 Asia Pacific
5.11.2.4 Rest Of The World
5.12 Porter’s Five Forces Analysis
5.12.1 Threat Of New Entrants
5.12.2 Threat Of Substitutes
5.12.3 Bargaining Power Of Buyers
5.12.4 Bargaining Power Of Suppliers
5.12.5 Intensity Of Competitive Rivalry
5.13 Key Stakeholders And Buying Criteria
5.13.1 Key Stakeholders
5.13.2 Buying Criteria
5.14 Investment And Funding Scenario
5.15 Trends/Disruptions Impacting Customers’ Businesses
5.16 Impact Of Ai/Gen Ai On Gene Delivery Technologies Market

6 Gene Delivery Technologies Market, By Product
6.1 Introduction
6.2 Reagents, Kits, And Assays
6.2.1 Increasing Demand For Transfection And Gene Editing Tools To Drive Market Growth
6.3 Consumables
6.3.1 Rising R&D Activity To Support Demand Growth
6.4 Instruments
6.4.1 Increasing Adoption Of Electroporation Devices To Drive Market
6.5 Other Products

7 Gene Delivery Technologies Market, By Mode
7.1 Introduction
7.2 Viral Vectors
7.2.1 Retroviruses
7.2.1.1 Lentiviruses
7.2.1.1.1 Rising Disease Incidence To Drive Market
7.2.1.2 Other Retroviruses
7.2.2 Adenoviruses
7.2.2.1 Expansion Of Vaccination Programs To Propel Market Growth
7.2.3 Adeno-associated Viruses
7.2.3.1 Low Immunogenicity Of Aav Vectors To Support Adoption
7.2.4 Other Viral Vectors
7.3 Non-viral Vectors
7.3.1 Chemical Methods
7.3.2 Liposome-mediated
7.3.2.1 High Efficiency And Compatibility To Drive Market
7.3.3 Calcium Phosphate
7.3.3.1 Increasing R&D In Cell-based Therapies To Propel Market Growth
7.3.4 Deae-dextran
7.3.4.1 Simplicity And Cost-effectiveness To Support Adoption
7.3.5 Cationic Polymers
7.3.5.1 Advancements In Cationic Polymer Technology To Drive Market
7.3.6 Other Chemical Methods
7.4 Physical Methods
7.4.1 Electroporation
7.4.1.1 Rising Demand For Effective Cell Transfection Technologies To Drive Market
7.4.2 Microinjection
7.4.2.1 High Accuracy And Control And Potential For Tailored Delivery To Drive Market
7.4.3 Gene Guns
7.4.3.1 High Efficiency Of Gene Guns In Transfecting Various Cell Types To Drive Market
7.4.4 Other Physical Methods

8 Gene Delivery Technologies Market, By Method
8.1 Introduction
8.2 In Vivo
8.2.1 Emergence Of Mrna-based Vaccines To Propel In Vivo Gene Delivery Applications
8.3 Ex Vivo
8.3.1 Successful Commercialization Of Car T-cell Therapies To Drive The Ex Vivo Gene Delivery Market
8.4 In Vitro
8.4.1 Databases Majorly Contribute To Storing Gene Delivery Technologies And Integrating Other Omics Databases.

9 Gene Delivery Technologies Market, By Application
9.1 Introduction
9.2 Therapeutic Applications
9.2.1 Gene Therapy
9.2.1.1 Increasing Demand For Personalized Medicine To Support Market Growth
9.2.2 Cell Therapy
9.2.2.1 Rising Government Funding To Propel Market Growth
9.2.3 Vaccines
9.2.3.1 Rising Prevalence Of Infectious Diseases To Drive Market Growth
9.2.4 Other Therapeutic Applications
9.3 Research Applications
9.3.1 Drug Discovery & Development
9.3.1.1 Increased Funding For Gene Therapy Research To Drive Market Growth
9.3.1.2 Cancer
9.3.1.2.1 Rising Investment In Cancer Research To Drive Market
9.3.2 Infectious Diseases
9.3.2.1 Rising Incidence Of Infectious Disease To Drive Market Growth
9.3.3 Genetic & Neurological Disorders
9.3.3.1 Rising Burden Of Disorders To Drive Market
9.3.4 Autoimmune Diseases
9.3.4.1 Growing Prevalence Of Autoimmune Disorders To Ensure Demand For Therapeutic Solutions
9.3.5 Other Diseases
9.3.6 Other Research Applications
9.4 Other Applications

10 Gene Delivery Technologies Market, By End User
10.1 Introduction
10.2 Pharmaceutical & Biotechnology Companies
10.2.1 Pharmaceutical & Biotechnology Companies Segment To Dominate Market
10.3 Academic & Research Institutes
10.3.1 Increasing R&D And Growing Funding And Partnerships To Promote Market Growth
10.4 Other End Users

11 Gene Delivery Technologies Market, By Region
11.1 Introduction
11.2 North America
11.2.1 North America: Macroeconomic Outlook
11.2.2 Us
11.2.2.1 Us To Dominate North American Market Over Forecast Period
11.2.3 Canada
11.2.3.1 Strong Infrastructure And Availability Of Funding For Biomedical Research To Support Market Growth
11.3 Europe
11.3.1 Europe: Macroeconomic Outlook
11.3.2 Germany
11.3.2.1 Germany To Hold Largest Market Share In Europe
11.3.3 Uk
11.3.3.1 Increasing Government Funding To Drive Market Growth
11.3.4 France
11.3.4.1 Rising Support For Genetic Research To Offer Potential Growth Opportunities
11.3.5 Italy
11.3.5.1 Rising R&D And Support For Gene Delivery To Drive Market
11.3.6 Spain
11.3.6.1 Growing Expansion Of Research Centers To Stimulate Market
11.3.7 Rest Of Europe
11.4 Asia Pacific
11.4.1 Asia Pacific: Macroeconomic Outlook
11.4.2 China
11.4.2.1 Increasing R&D Expenditure To Drive Market Growth
11.4.3 Japan
11.4.3.1 Rising Research Into Precision Medicine To Support Market Growth
11.4.4 India
11.4.4.1 Strong Research Base And Rising Fdi In Pharma Sector To Support Market Growth
11.4.5 South Korea
11.4.5.1 Alliances & Investments In Research To Drive Market
11.4.6 Australia
11.4.6.1 Increasing Focus On Precision Medicine To Offer Significant Growth Opportunities
11.4.7 Rest Of Asia Pacific
11.5 Latin America
11.5.1 Latin America: Macroeconomic Outlook
11.5.2 Brazil
11.5.2.1 Brazil To Hold Largest Market Share In Latam
11.5.3 Mexico
11.5.3.1 Strong Pharmaceutical Industry And Increased Government Support To Augment Market Growth
11.5.4 Rest Of Latin America
11.6 Middle East
11.6.1 Middle East: Macroeconomic Outlook
11.6.2 Gcc Countries
11.6.2.1 Saudi Arabia
11.6.2.1.1 Increasing Government Investments In Healthcare And Growing Pharmaceuticals Industry To Support Market
11.6.2.2 Uae
11.6.2.2.1 Growing R&D Expenditure And Infrastructural Development To Drive Market
11.6.2.3 Rest Of Gcc Countries
11.6.3 Rest Of Middle East
11.7 Africa
11.7.1 Rising Emphasis On Gene Delivery Technologies For Therapeutics To Support Market Growth
11.7.2 Macroeconomic Outlook For Africa

12 Competitive Landscape
12.1 Overview
12.2 Key Player Strategies/Right To Win
12.2.1 Overview Of Strategies Adopted By Players In Gene Delivery Technologies Market
12.3 Revenue Analysis
12.4 Market Share Analysis
12.5 Company Evaluation Matrix: Key Players, 2023
12.5.1 Stars
12.5.2 Emerging Leaders
12.5.3 Pervasive Players
12.5.4 Participants
12.5.5 Company Footprint: Key Players, 2023
12.5.5.1 Company Footprint
12.5.5.2 Region Footprint
12.5.5.3 Product Footprint
12.5.5.4 Method Footprint
12.5.5.5 Application Footprint
12.5.5.6 End-user Footprint
12.6 Company Evaluation Matrix: Startups/Smes, 2023
12.6.1 Progressive Companies
12.6.2 Responsive Companies
12.6.3 Dynamic Companies
12.6.4 Starting Blocks
12.6.5 Competitive Benchmarking: Startups/Smes, 2023
12.7 Company Valuation & Financial Metrics
12.7.1 Financial Metrics
12.7.2 Company Valuation
12.8 Brand/Product Comparison
12.9 Competitive Scenario
12.9.1 Product Launches
12.9.2 Deals
12.9.3 Expansions

13 Company Profiles
13.1 Key Players
13.1.1 Thermo Fisher Scientific Inc.
13.1.1.1 Business Overview
13.1.1.2 Products/Services/Solutions Offered
13.1.1.3 Recent Developments
13.1.1.3.1 Product Launches
13.1.1.3.2 Expansions
13.1.1.4 Mnm View
13.1.1.4.1 Key Strengths
13.1.1.4.2 Strategic Choices
13.1.1.4.3 Weaknesses And Competitive Threats
13.1.2 Danaher Corporation
13.1.2.1 Business Overview
13.1.2.2 Products/Services/Solutions Offered
13.1.2.3 Recent Developments
13.1.2.3.1 Product Launches
13.1.2.3.2 Deals
13.1.2.3.3 Expansions
13.1.2.4 Mnm View
13.1.2.4.1 Key Strengths
13.1.2.4.2 Strategic Choices
13.1.2.4.3 Weaknesses And Competitive Threats
13.1.3 Merck Kgaa
13.1.3.1 Business Overview
13.1.3.2 Products/Services/Solutions Offered
13.1.3.3 Recent Developments
13.1.3.3.1 Deals
13.1.3.3.2 Expansions
13.1.3.4 Mnm View
13.1.3.4.1 Key Strengths
13.1.3.4.2 Strategic Choices
13.1.3.4.3 Weaknesses And Competitive Threats
13.1.4 Bio-rad Laboratories, Inc.
13.1.4.1 Business Overview
13.1.4.2 Products/Services/Solutions Offered
13.1.5 Agilent Technologies, Inc.
13.1.5.1 Business Overview
13.1.5.2 Products/Services/Solutions Offered
13.1.5.3 Recent Developments
13.1.5.3.1 Deals
13.1.6 Revvity
13.1.6.1 Business Overview
13.1.6.2 Products/Services/Solutions Offered
13.1.6.3 Recent Developments
13.1.6.3.1 Product Launches
13.1.6.3.2 Deals
13.1.7 Qiagen
13.1.7.1 Business Overview
13.1.7.2 Products/Services/Solutions Offered
13.1.8 Genscript
13.1.8.1 Business Overview
13.1.8.2 Products/Services/Solutions Offered
13.1.8.3 Recent Developments
13.1.8.3.1 Deals
13.1.9 Takara Bio Inc.
13.1.9.1 Business Overview
13.1.9.2 Products/Services/Solutions Offered
13.1.9.3 Recent Developments
13.1.9.3.1 Product Launches
13.1.9.3.2 Deals
13.1.10 Promega Corporation
13.1.10.1 Business Overview
13.1.10.2 Products/Services/Solutions Offered
13.1.11 Bio-techne
13.1.11.1 Business Overview
13.1.11.2 Products/Services/Solutions Offered
13.1.11.3 Recent Developments
13.1.11.3.1 Product Launches
13.1.12 Lonza
13.1.12.1 Business Overview
13.1.12.2 Products/Services/Solutions Offered
13.1.12.3 Recent Developments
13.1.12.3.1 Product Launches
13.1.12.3.2 Deals
13.1.13 Oxford Biomedica Plc
13.1.13.1 Business Overview
13.1.13.2 Products/Services/Solutions Offered
13.1.13.3 Recent Developments
13.1.13.3.1 Product Launches
13.1.13.3.2 Deals
13.1.13.3.3 Other Developments
13.1.14 Sartorius Ag
13.1.14.1 Business Overview
13.1.14.2 Products/Services/Solutions Offered
13.1.14.3 Recent Developments
13.1.14.3.1 Product Launches
13.1.14.3.2 Deals
13.1.15 Maxcyte
13.1.15.1 Business Overview
13.1.15.2 Products/Services/Solutions Offered
13.1.15.3 Recent Developments
13.1.15.3.1 Deals
13.2 Other Players
13.2.1 Cell Biolabs, Inc.
13.2.2 Gentarget Inc.
13.2.3 Origene Technologies, Inc.
13.2.4 Altogen Biosystems
13.2.5 Oz Biosciences
13.2.6 Genecopoeia, Inc.
13.2.7 Creative Biolabs
13.2.8 Synbio Technologies Llc
13.2.9 System Biosciences, Llc
13.2.10 Vectorbuilder Inc.

14 Appendix
14.1 Discussion Guide
14.2 Knowledgestore: Marketsandmarkets’ Subscription Portal
14.3 Customization Options
14.4 Related Reports
14.5 Author Details